Clinical Trials Directory

Trials / Completed

CompletedNCT01812564

Use of Platelet Rich Plasma in the Management of Acute Hamstring Muscle Strain Injury

Clinical Utilization of Growth Factors Preparations in the Management of Acute Hamstring Muscle Strain Injury

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Aspetar · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the therapeutic benefit of utilizing complex growth factor preparations (Platelet Rich Plasma (PRP) in the management of acute hamstring injuries. The hypothesis is that the time to return to sport is shorter in the patient group treated with Complex Growth Factor Preparations (PRP) in combination with exercise therapy in comparison with 2 control groups: * the patient group treated with Platelet Poor Plasma (PPP) injections in combination with exercise therapy (control injection AND usual care). * the patient group treated with exercise therapy (usual care)

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlatelet Poor Plasma (PPP)
BIOLOGICALPlatelet Rich Plasma (PRP)

Timeline

Start date
2009-11-01
Primary completion
2013-10-01
Completion
2014-10-01
First posted
2013-03-18
Last updated
2015-01-14

Locations

1 site across 1 country: Qatar

Source: ClinicalTrials.gov record NCT01812564. Inclusion in this directory is not an endorsement.

Use of Platelet Rich Plasma in the Management of Acute Hamstring Muscle Strain Injury (NCT01812564) · Clinical Trials Directory